V.R. Doherty

2.3k total citations
39 papers, 1.6k citations indexed

About

V.R. Doherty is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, V.R. Doherty has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Dermatology and 11 papers in Epidemiology. Recurrent topics in V.R. Doherty's work include Cutaneous Melanoma Detection and Management (20 papers), CAR-T cell therapy research (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). V.R. Doherty is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), CAR-T cell therapy research (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). V.R. Doherty collaborates with scholars based in United Kingdom, India and Ireland. V.R. Doherty's co-authors include David Brewster, Diane Stockton, D. McKenna, R. M. MacKie, David W. Melton, R.M. MACKIE, Thomas Brenn, R.M. MacKie, Ewan Brown and Yan Xu and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

V.R. Doherty

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.R. Doherty United Kingdom 23 765 588 581 398 182 39 1.6k
Magnus Thörn Sweden 30 993 1.3× 407 0.7× 492 0.8× 338 0.8× 206 1.1× 59 2.2k
Peter Kaskel Germany 18 458 0.6× 394 0.7× 271 0.5× 541 1.4× 180 1.0× 43 1.5k
Jerry Marsden United Kingdom 19 862 1.1× 420 0.7× 524 0.9× 403 1.0× 87 0.5× 32 1.6k
Anne Østerlind Denmark 26 1.2k 1.6× 598 1.0× 944 1.6× 363 0.9× 135 0.7× 51 2.3k
J.M. McGregor United Kingdom 24 577 0.8× 730 1.2× 609 1.0× 215 0.5× 45 0.2× 50 1.5k
Arthur R. Rhodes United States 26 1.6k 2.1× 578 1.0× 1.0k 1.8× 351 0.9× 147 0.8× 60 2.4k
Ivor Caro United States 25 572 0.7× 505 0.9× 813 1.4× 670 1.7× 56 0.3× 65 2.2k
J J Bonerandi France 19 742 1.0× 369 0.6× 452 0.8× 317 0.8× 30 0.2× 43 1.3k
P Souteyrand France 25 862 1.1× 452 0.8× 721 1.2× 410 1.0× 41 0.2× 92 2.1k
Onofre Sanmartín Spain 20 640 0.8× 403 0.7× 515 0.9× 218 0.5× 80 0.4× 87 1.4k

Countries citing papers authored by V.R. Doherty

Since Specialization
Citations

This map shows the geographic impact of V.R. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.R. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.R. Doherty more than expected).

Fields of papers citing papers by V.R. Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.R. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.R. Doherty. The network helps show where V.R. Doherty may publish in the future.

Co-authorship network of co-authors of V.R. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of V.R. Doherty. A scholar is included among the top collaborators of V.R. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.R. Doherty. V.R. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doherty, V.R., et al.. (2012). Multiple Keratotic Papules on the Palm and Fingers. American Journal of Dermatopathology. 37(8). 620–620. 2 indexed citations
2.
Brown, Ewan, Niall Anderson, Thomas Brenn, et al.. (2011). Association of galectin-3 expression with melanoma progression and prognosis. European Journal of Cancer. 48(6). 865–874. 51 indexed citations
3.
Brewster, David, et al.. (2007). Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003. British Journal of Dermatology. 156(6). 1295–1300. 102 indexed citations
4.
MACKIE, R.M., Caroline A. Bray, J.P. VESTEY, et al.. (2007). Melanoma incidence and mortality in Scotland 1979–2003. British Journal of Cancer. 96(11). 1772–1777. 86 indexed citations
5.
Mowbray, Max, et al.. (2007). Changes in the site distribution of malignant melanoma in South East Scotland (1979–2002). British Journal of Cancer. 96(5). 832–835. 10 indexed citations
6.
McKenna, D., et al.. (2004). A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. British Journal of Dermatology. 151(3). 636–644. 54 indexed citations
8.
McKenna, D., et al.. (2002). The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. British Journal of Dermatology. 147(1). 48–54. 57 indexed citations
9.
Stockton, Diane, V.R. Doherty, & David Brewster. (2001). Risk of cancer in patients with dermatomyositis or polymyositis and follow-up implications: a Scottish population-based cohort study. British Journal of Cancer. 85(1). 41–45. 205 indexed citations
10.
McKenna, D., V.R. Doherty, K M McLaren, & John Hunter. (2000). Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?. British Journal of Dermatology. 143(1). 171–173. 44 indexed citations
11.
McLaren, K M, et al.. (2000). Equestrian perniosis associated with cold agglutinins: a novel finding. Clinical and Experimental Dermatology. 25(4). 285–288. 21 indexed citations
12.
Doherty, V.R., et al.. (1995). 'Naevophobia'. Clinical and Experimental Dermatology. 20(6). 499–501. 1 indexed citations
13.
O'Grady, Jane, H. Shahidullah, V.R. Doherty, & A. Al‐Nafussi. (1994). Intravascular histiocytosis. Histopathology. 24(3). 265–268. 54 indexed citations
14.
McHenry, P.M. & V.R. Doherty. (1992). Psoriasis: an audit of patients' views on the disease and its treatment. British Journal of Dermatology. 127(1). 13–13. 47 indexed citations
15.
Stables, G.I., V.R. Doherty, & R. M. MacKie. (1992). Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma. British Journal of Dermatology. 127(5). 505–508. 5 indexed citations
16.
Williams, Richard, V.R. Doherty, William Perkins, T Aitchison, & R.M. MACKIE. (1992). Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. British Journal of Dermatology. 126(4). 362–366. 28 indexed citations
17.
Doherty, V.R. & R. M. MacKie. (1988). Experience of a public education programme on early detection of cutaneous malignant melanoma.. BMJ. 297(6645). 388–391. 102 indexed citations
18.
Roberts, David T., R. J. Hay, V.R. Doherty, Malcolm Richardson, & Y.M. CLAYTON. (1988). Topical Treatment of Onychomycosis Using Bifonazole 1% Urea/40% Paste. Annals of the New York Academy of Sciences. 544(1). 586–587. 14 indexed citations
19.
Doherty, V.R. & R.M. MacKie. (1986). Reasons for poor prognosis in British patients with cutaneous malignant melanoma.. BMJ. 292(6526). 987–989. 77 indexed citations
20.
Jones, Stephen, V.R. Doherty, & Ann Forsyth. (1983). Causes and management of anal irritation. BMJ. 287(6407). 1801.1–1801.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026